Accelerate Diagnostics Inc EV/EBIT
Cos'è EV/EBIT di Accelerate Diagnostics Inc?
EV/EBIT di Accelerate Diagnostics Inc è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Accelerate Diagnostics Inc
Cosa fa Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Aziende con ev/ebit simili a Accelerate Diagnostics Inc
- Centogene NV ha EV/EBIT di N/A
- Delek US Inc ha EV/EBIT di N/A
- Freeport Resources ha EV/EBIT di N/A
- AMMO ha EV/EBIT di N/A
- AMMO ha EV/EBIT di N/A
- Ultragenyx Pharmaceutical ha EV/EBIT di N/A
- Accelerate Diagnostics Inc ha EV/EBIT di N/A
- Eros International Plc ha EV/EBIT di N/A
- Deveron UAS ha EV/EBIT di N/A
- HT Media ha EV/EBIT di N/A
- Aguila American Gold ha EV/EBIT di N/A
- Sri Adhikari Brothers Television Network ha EV/EBIT di N/A
- Zicom Electronic Security Systems ha EV/EBIT di N/A